Douglas CDMO Capacity Update July 2024: Small Molecule Finished Dosage Form

Douglas CDMO, part of Douglas Pharmaceuticals, is one of New Zealand's largest privately owned companies. They specialize in high-potency softgels and liquids and have deep experience producing prescription drugs for classifications including oncology, dermatology, the central nervous system and immunity. As one of the primary suppliers of pharmaceutical softgels to the United States and European markets, Douglas CDMO provides approximately a third of the available softgels. Alongside a commitment to delivering high quality products, the organization prioritizes excellent service, aiming to be a preferred CDMO partner for ease of doing business, responsiveness and problem-solving.